Table 2.

SIR for cancer of patient with urolithiasis, 1987–2012.

	Follow-up (years)
	<1				1–9				10+
Cancer site	O	SIR	95% CI		O	SIR	95% CI		O	SIR	95% CI
Colon	243	3.91	3.44	4.44	888	1.36	1.28	1.46	396	1.28	1.16	1.42
Pancreas	79	4.80	3.80	5.99	267	1.62	1.43	1.83	94	1.38	1.12	1.69
Lung	171	2.87	2.45	3.33	773	1.26	1.18	1.36	300	1.12	0.99	1.25
Breast	146	2.46	2.08	2.89	769	1.27	1.18	1.36	356	1.28	1.15	1.42
Prostate	1029	4.89	4.60	5.20	2602	1.17	1.13	1.22	1301	1.22	1.16	1.29
Kidney	400	22.40	20.26	24.70	366	1.68	1.52	1.87	112	1.56	1.29	1.88
Urinary bladder	596	14.02	12.92	15.20	614	1.39	1.28	1.50	264	1.30	1.15	1.46
Melanoma	99	2.39	1.94	2.91	556	1.32	1.21	1.43	259	1.35	1.19	1.52
Other sites	1473	3.76	3.57	3.95	5324	1.34	1.31	1.38	2126	1.22	1.17	1.28
All	4236	4.70	4.56	4.84	12159	1.31	1.29	1.33	5208	1.24	1.21	1.28

Bold type: 95% CI does not include 1.00.

O = observed number of cases; SIR = standardized incidence ratio; CI = confidence interval.